Insider Transactions Reported by 17 Insiders of Eiger BioPharmaceuticals, Inc.

Location
Palo Alto, CA

There are no Buy or Sell transactions made by insiders since 06 Jan 2025

Eiger BioPharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RICHARD A. KAYNE 10%+ Owner $1,600,204 31 Oct 2023
LEEN KAWAS 10%+ Owner $1,307,329 31 Oct 2023
David A. Cory President and CEO, Director $50,366 11 Mar 2022
Eldon C. Mayer III Ex VP & Chief Commerc. Officer $16,693 17 Mar 2023
Sriram Ryali Chief Financial Officer $12,374 14 Mar 2022
Ingrid Choong Chief Business Officer $9,972 31 Aug 2023
Erik Atkisson GC & Chief Compliance Officer 26 Jan 2023
David Apelian CEO, Director 03 Jul 2023
Jeffrey S. Glenn Director 01 Mar 2023
Kim Sablich Director 01 Mar 2023
Amit Sachdev Director 01 Mar 2023
Christine Murray Director 01 Mar 2023
Lisa Kelly-Croswell Director 01 Mar 2023
William G. Kachioff Cfo 12 Apr 2023
Thomas John Dietz Director 01 Mar 2023
James Vollins General Counsel 30 Apr 2023
Evan Loh Director 01 Mar 2023

Recent Insider Transactions by Companies or Individuals for Eiger BioPharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.